Diagnostic performance of pet imaging using different radiopharmaceuticals in prostate cancer according to published meta-analyses

HIGHLIGHTS

• who: Salvatore Annunziata et al. from the Department of Nuclear Medicine, Universitaetsspital Zuerich, Zürich, Switzerland Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of have published the paper: Diagnostic Performance of PET Imaging Using Different Radiopharmaceuticals in Prostate Cancer According to Published Meta-Analyses, in the Journal: Cancers 2020, 12, 2153 of /2020/
• what: The aim of this review is to summarize information retrieved by published meta-analyses on this topic.
• future: More prospective multicentric studies and cost-effectiveness analyses are warranted. Based on current evidence-based data . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.